🇨🇭

PolyPeptide Group

Public

European peptide CDMO

PolyPeptide Group is a Swedish-Swiss contract manufacturer specializing in peptide-based APIs for the pharma industry. With facilities across Europe, the US, and India, PolyPeptide is scaling capacity to meet surging GLP-1 and obesity peptide demand, though it has faced operational challenges balancing growth with quality.

Founded1996

HQBaar, Switzerland

CEOJuan José González

TickerSIX Swiss Exchange:PPGN

Total FundingN/A (Public since 2021)

Pipeline

Drug / Program	Indication	Phase	Technology
Contract Manufacturing	Multiple customers	Commercial	SPPS + LPPS

Key People

Juan José GonzálezCEO

Peptide CDMOs: The GLP-1 Manufacturing Bottleneck Explained

Peptide Therapeutics

Market Analysis

Peptide CDMOs: The GLP-1 Manufacturing Bottleneck Explained

Why peptide manufacturing became the GLP-1 bottleneck. A 2026 investor guide to Bachem, PolyPeptide, Lonza, and the peptide CDMO pick-and-shovel trade.

Apr 8, 202611 min read

Pipeline

Key People

Related Articles

Peptide CDMOs: The GLP-1 Manufacturing Bottleneck Explained